Location of MBL-Associated Serine Proteases Binding Motifs on Human Mannan-Binding Lectin (MBL)

被引:4
|
作者
Zuo, Daming [1 ]
Cai, Xuemin [1 ]
Zhao, Na [1 ]
Zhang, Liyun [1 ]
Chen, Zhengliang [1 ]
机构
[1] So Med Univ, Dept Immunol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China
来源
PROTEIN AND PEPTIDE LETTERS | 2010年 / 17卷 / 01期
关键词
Mannan-binding lectin (MBL); collagen-like region (CLR); interruption; MBL-associated serine proteases (MASPs); binding motifs; synthetic peptides; COMPLEMENT ACTIVATION; PROTEIN; PATHWAY; MASPS; IDENTIFICATION; MUTATIONS; IMMUNITY; DISEASE; SITE;
D O I
10.2174/092986610789909566
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lectin pathway provides an antibody independent route of complement activation. Mannan-binding lectin (MBL) can form compound with MBL-associated serine proteases (MASPs) through its collagen-like region (CLR) to initiate complement fixation. In this study, we designed and synthesized a range of peptides according to the sequence of CLR in human MBL, which were assumed to block the MBL-MASP interaction, in order to locate the serine protease binding motifs on human MBL. It was demonstrated that MASPs bind on the C-terminal side of the hinge region formed by an interruption in the Gly-X-Y repeat pattern of the collagen-like domain. In addition, Arg32Cys, Gly35Asp and Gly37Glu mutant proteins have the similar serine protease binding characteristic with wild type MBL, but the binding between mutated MBL proteins and MASPs is much weaker than that between wild type MBL protein and MASPs.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 50 条
  • [31] Fasciola hepatica is refractory to complement killing by preventing attachment of mannose binding lectin (MBL) and inhibiting MBL-associated serine proteases (MASPs) with serpins
    De Marco Verissimo, Carolina
    Jewhurst, Heather L.
    Dobo, Jozsef
    Gal, Peter
    Dalton, John P.
    Cwiklinski, Krystyna
    PLOS PATHOGENS, 2022, 18 (01)
  • [32] Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans
    Valdimarsson, H
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 768 - 769
  • [33] Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans
    Valdimarsson, H
    Stefansson, M
    Vikingsdottir, T
    Arason, GJ
    Koch, C
    Thiel, S
    Jensenius, JC
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1998, 48 (02) : 116 - 123
  • [34] Regulation of the MBL-associated serine proteases (MASPs)
    Kojima, M
    Hajela, K
    Whaley, K
    Schwaeble, W
    Sim, RB
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 102 - 102
  • [35] Activation properties of MBL-associated serine proteases
    Zundel, S
    Cseh, S
    Lacroix, M
    Dahl, M
    Matsushita, M
    Jensenius, J
    Fujita, T
    Arlaud, GJ
    Thielens, NM
    MOLECULAR IMMUNOLOGY, 2003, 40 (2-4) : 200 - 200
  • [36] Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex
    Brown, K. S.
    Keogh, M. J.
    Tagiuri, N.
    Grainge, M. J.
    Presanis, J. S.
    Ryder, S. D.
    Irving, W. L.
    Ball, J. K.
    Sim, R. B.
    Hickling, T. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (01): : 90 - 98
  • [37] Serum levels, ontogeny and heritability of chicken mannan-binding lectin (MBL)
    Laursen, SB
    Hedemand, JE
    Nielsen, OL
    Thiel, S
    Koch, C
    Jensenius, JC
    IMMUNOLOGY, 1998, 94 (04) : 587 - 593
  • [38] Mannan-binding lectin (MBL) polymorphisms and protein levels in pulmonary tuberculosis
    Santos, P
    Lopes, J
    Gomes, JM
    Pereira, L
    Freitas, A
    Domingos, A
    Regateiro, F
    Segorbe-Luis, A
    GENES AND IMMUNITY, 2004, 5 : S39 - S39
  • [39] Consensus statement on the future of mannan-binding lectin (MBL)-replacement therapy
    Kilpatrick, DC
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 776 - 776
  • [40] Surgical trauma and the mannan-binding lectin (MBL) pathway of innate immunity
    Ytting, H
    Christensen, IJ
    Thiel, S
    Jensenius, JC
    Nielsen, HJ
    CLINICAL IMMUNOLOGY, 2005, 115 : S70 - S70